5 results

More filter Other Filter Icon

Other Filter Icon

Search Export

2023 update: clinical utility of genomic signatures in early-stage HR-positive/HER2-negative breast cancer - InaHTA Brief

Health technology assessment - Posted on 22/11/2023

Download document

Add to my selection
Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Health technology assessment - Posted on 29/09/2023

Download document

Add to my selection
Usefulness of contrast-enhanced mammography in breast cancer diagnosis strategy - INAHTA Brief

Health technology assessment - Posted on 22/11/2021 - Mis à jour le 22/11/2021

Download document

Add to my selection
Assessment of tissue or cell sample preparation, qualification and selection procedures for cancer somatic gene testing - INAHTA Brief

Health technology assessment - Posted on 27/12/2019 - Mis à jour le 27/12/2019

Download document

Add to my selection
Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Health technology assessment - Posted on 11/02/2019

Download document

Add to my selection